|Koninklijke DSM N V -- USA Stock|| |
USD 24.94 0.000001 0.00%
Member of the Supervisory Board
Dr. Victoria Haynes has served as Independent Member of the Supervisory Board of Royal DSM NV since May 11, 2012. The last position she held was President and CEO of the Research Triangle Institute International. Currently she serves as Member of the Board of Directors of PPG, Nucor and, as of 2013, Axiall. She is Member of the Company Audit Committee.
Age: 69 Executive Since 2012 Ph.D
31 45 578 2864 http://www.dsm.com
Victoria Haynes Latest Insider Activity
The company has return on total asset (ROA)
of 3.87 %
which means that it generated profit of $3.87 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 26.89 %
meaning that it generated $26.89 on every $100 dollars invested by stockholders.
The company has accumulated 3.26 B in total debt with debt to equity ratio (D/E) of 37.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Koninklijke DSM N V has Current Ratio of 2.39 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
|Found 1 records|
|Chris Suh||Microsoft Corporation|
Koninklijke DSM N.V., a science-based company, engages in health, nutrition, and materials businesses worldwide. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands. Koninklijke DSM is traded on OTC Market in USA.Koninklijke DSM N V (RDSMY) is traded on OTC Market in USA. It is located in Het Overloon 1 and employs 21,054 people.